Literature DB >> 8677265

Expression of thrombospondin-1 in cancer: a role in tumor progression.

X Qian1, G P Tuszynski.   

Abstract

Thrombospondin-1 (TSP-1), a trimeric high molecular weight glycoprotein, is one of the major secreted proteins of human platelets and an extracellular matrix component of a variety of cells including vascular endothelial cells and tumor cells. TSP-1 has been shown to be highly expressed in human malignant tissues and present in higher than normal levels in the plasma of cancer patients. TSP-1 has also been shown to promote hematogenous tumor spread, tumor cell adhesion and invasion, and angiogenesis. Overall these studies provide compelling evidence for the conclusion that TSP-1 plays an important role in tumor progression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8677265     DOI: 10.3181/00379727-212-44008

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  23 in total

1.  Treatment of experimental brain tumors with trombospondin-1 derived peptides: an in vivo imaging study.

Authors:  A Bogdanov; E Marecos; H C Cheng; L Chandrasekaran; H C Krutzsch; D D Roberts; R Weissleder
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritic cartilage.

Authors:  D Pfander; T Cramer; D Deuerling; G Weseloh; B Swoboda
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

3.  Expression of thrombospondin-1 in human pancreatic adenocarcinomas: role in matrix metalloproteinase-9 production.

Authors:  X Qian; V L Rothman; R F Nicosia; G P Tuszynski
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

4.  Prognostic value of combined platelet, fibrinogen, neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with lung adenosquamous cancer.

Authors:  Yu-Qian Wang; Qiong-Jie Zhi; Xin-Yue Wang; Dong-Sheng Yue; Kai Li; Ri-Cheng Jiang
Journal:  Oncol Lett       Date:  2017-07-24       Impact factor: 2.967

5.  Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance.

Authors:  A Radziwon-Balicka; C Medina; L O'Driscoll; A Treumann; D Bazou; I Inkielewicz-Stepniak; A Radomski; H Jow; M W Radomski
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

6.  Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization.

Authors:  K Bleuel; S Popp; N E Fusenig; E J Stanbridge; P Boukamp
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression.

Authors:  Carmelo Nucera; Alessandro Porrello; Zeus Andrea Antonello; Michal Mekel; Matthew A Nehs; Thomas J Giordano; Damien Gerald; Laura E Benjamin; Carmen Priolo; Efisio Puxeddu; Stephen Finn; Barbara Jarzab; Richard A Hodin; Alfredo Pontecorvi; Vânia Nose; Jack Lawler; Sareh Parangi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

8.  Thrombospondin-1 (TSP-1) Stimulates Expression of Integrin alpha6 in Human Breast Carcinoma Cells: A Downstream Modulator of TSP-1-Induced Cellular Adhesion.

Authors:  Anitha S John; Vicki L Rothman; George P Tuszynski
Journal:  J Oncol       Date:  2010-07-07       Impact factor: 4.375

9.  Thrombospondin-1 expression correlates with angiogenesis in experimental cirrhosis.

Authors:  Gulsum-Ozlem Elpek; Guzide-Ayse Gokhan; Sevgi Bozova
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

10.  Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor.

Authors:  Carolien Boeckx; Lina Blockx; Ken Op de Beeck; Ridha Limame; Guy Van Camp; Marc Peeters; Jan B Vermorken; Pol Specenier; An Wouters; Marc Baay; Filip Lardon
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.